Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis.

Reed, George W; Gerber, Robert A; Shan, Ying; Takiya, Liza; Dandreo, Kimberly J; Gruben, David; Kremer, Joel; Wallenstein, Gene

Reed, George W; Gerber, Robert A; Shan, Ying; Takiya, Liza; Dandreo, Kimberly J; Gruben, David; Kremer, Joel; Wallenstein, Gene.

Afiliação

Reed GW; Corrona Research Foundation, Albany, NY, USA. greed@corrona.org.
Gerber RA; University of Massachusetts Medical School, Worcester, MA, USA. greed@corrona.org.
Shan Y; Pfizer Inc, Groton, CT, USA.
Takiya L; Corrona, LLC, Waltham, MA, USA.
Dandreo KJ; Pfizer Inc, Collegeville, PA, USA.
Gruben D; Corrona, LLC, Waltham, MA, USA.
Kremer J; Pfizer Inc, Groton, CT, USA.
Wallenstein G; Albany Medical College, Albany, NY, USA.

Rheumatol Ther ; 2019 Nov 09.

Article em En | MEDLINE | ID: mdl-31707603